Manufacturer of combined-energy medical aesthetic devices, Syneron Medical Ltd., has announced the commercial launch of the Elure topical whitening products in several Asian markets.
The Elure advanced dermal whitening product is an enzymatic skin whitening treatment that targets and decomposes melanin to reveal a lighter and more luminous skin tone. This product line is based on the naturally occurring bio-active substance, Melanozyme, working in cooperation with scientists in the field of biotechnology and enzymes, and cosmetics experts. Melanozyme acts to decompose the melanin in a clinically proven, fast and safe manner with no side effects. It is combined with a bioactivator to diminish the dark coloured pigment in the skin. Unlike several other whitening products in the market, the Elure product line does not contain hydroquinine which may cause side effects such as skin redness and burning sensation.
